封面
市場調查報告書
商品編碼
1197757

核酸分離純化市場增長、趨勢、COVID-19 的影響和預測 (2023-2028)

Nucleic Acid Isolation and Purification Market - Growth, Trends, and Forecasts (2023 - 2028)

出版日期: | 出版商: Mordor Intelligence | 英文 112 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內,核酸分離純化市場預計將以 6.6% 的複合年增長率增長。

核酸分離和純化市場的增長得益於快速的技術進步、核酸檢測在診斷領域的廣泛應用,以及生物技術和醫療保健領域研發資金的增加。

主要亮點

  • 核酸用於許多疾病的診斷測試,包括性傳播疾病、出生缺陷和癌症。
  • 根據美國衛生與公眾服務部的數據,截至 2016 年,全球約有 3670 萬艾滋病毒/艾滋病感染者。 其中,210 萬是兒童(15 歲及以上)。 世界衛生組織表示,全世界每天有超過 100 萬人感染性傳播疾病,其中 5 億人感染了單純皰疹病毒 (HSV) 的生殖器,2.9 億女性感染了人乳頭瘤病毒 (HPV)。我假設它已被感染。 因此,所有性傳播疾病都可以通過核酸分離鑑定程序進行診斷,這意味著研究目標市場有望在全球範圍內擴大。
  • 此外,聚合酵素鍊式反應(最初的核酸擴增技術)等快速技術進步改變了臨床微生物學家看待和使用核酸技術的方式,目前的市場正在不斷擴大。

核酸分離純化市場趨勢

核酸分離純化市場,設備板塊有望佔據較大份額

  • 在接受調查的市場中,設備行業呈穩定增長態勢。 分子診斷領域的重大進步正在推動核酸分離和純化技術的快速和持續進步。 在繪製許多疾病背後的遺傳風險因素的新知識的推動下,生活方式正在發揮重要作用。
  • 根據世界衛生組織 (WHO) 2020 年版,ALPHA 和BETA 地中海貧血已被發現是全世界最常見的遺傳性單基因疾病。 在世界許多地方,地中海貧血的負擔是一個主要的公共衛生問題。 例如,在伊朗,估計每年約有 8,000 名孕婦有患該病的風險。 此外,據估計,全世界每 1,000 至 1,100 名活產嬰兒中就有 1 例患有唐氏綜合症,這是一種遺傳性疾病。
  • 因此,遺傳病的高發病率以及實驗室自動化程度和頑固性的提高可能會導致所研究市場設備部分的增長。

北美將佔據很大的市場份額,預計在預測期內也會如此

  • 由於下游用途的絕對數量,預計北美將在核酸分離和純化市場佔據主要市場份額。 市場增長還歸因於快速的技術進步、核酸檢測在推動市場的診斷中的廣泛應用,以及生物技術和醫療保健領域研發資金的增加。
  • 根據美國疾病控制和預防中心 (CDC) 的數據,美國每 5,000 名新生兒中就有 1 名患有 A 型血友病。 每年約有 400 名嬰兒出生時患有 A 型血友病。
  • 此外,完善的醫療保健基礎設施也在推動該地區整體市場的增長。

核酸分離純化市場競爭者分析

核酸分離純化市場是一個由幾家大型企業組成的分散且競爭激烈的市場。 全球核酸分離純化市場的近期市場趨勢包括新產品開發、併購和合作夥伴關係。 Agilent Technologies、Bio-Rad Laboratories Inc.、Danaher Corporation、F. Hoffmann-La Roche Ltd、GE Healthcare、Promega Corporation、Qiagen NV、Thermo Fisher Scientific Inc. 是核酸分離和純化市場的主要參與者。

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 調查結果
  • 調查假設
  • 本次調查的範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 通過快速的技術進步加速市場增長
    • 核酸檢測在診斷領域的廣泛應用推動了市場的發展
    • 增加生物技術和醫療保健領域的研發資金
  • 市場製約因素
    • 在新興市場的滲透率較低
    • 自動化設備成本上升
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分

  • 按技術
    • 基於柱的純化
    • 磁珠純化
    • 基於試劑的純化
  • 按產品分類
    • 試劑盒和試劑
    • 設備
    • 其他產品
  • 通過申請
    • 總RNA的分離和純化
    • mRNA的分離和純化
    • microRNA 的分離和純化
    • 質粒DNA的分離和純化
    • 基因組 DNA 的分離和純化
    • 血型DNA的分離純化
    • PCR 純化
    • 其他核酸分離和純化應用
  • 最終用戶
    • 醫院
    • 學術和研究機構
    • 製藥/生物技術
    • 其他最終用戶
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東和非洲地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Agilent Technologies
    • Bio-Rad Laboratories Inc.
    • Thermo Fisher Scientific
    • BioVision Inc.
    • Danaher Corporation
    • F. Hoffmann-La Roche Ltd
    • GE Healthcare
    • Merck KGaA(Sigma-Aldrich Corporation)
    • Promega Corporation
    • Qiagen NV

第7章 市場機會今後動向

簡介目錄
Product Code: 50452

The Nucleic Acid Isolation and Purification Market is expected to register a CAGR of 6.6% during the forecast period. growth of the nucleic acid isolation and purification market is due to the rapid technological advancements, wide-range applications of nucleic acid testing in diagnostics, and rise in the R&D funding in biotechnology and healthcare.

Key Highlights

  • Nucleic acid has many diagnostic applications in tests of many diseases, such as STDs, congenital anomalies, cancer, etc.
  • According to the US Department of Health & Human Services, there were approximately 36.7 million people worldwide living with HIV/AIDS as of 2016. Of these, 2.1 million were children (above 15 years old). The WHO stated that more than 1 million sexually transmitted infections are acquired every day worldwide and 500 million people are estimated to have genital infection with herpes simplex virus (HSV), along with 290 million women who have a human papillomavirus (HPV) infection. Therefore, all STDs can be diagnosed through nucleic acid isolation and identification procedures, and this signifies that the market studied is expected to increase globally.
  • The current market is also growing, due to rapid technological advancements, like polymerase chain reaction (the original nucleic acid amplification technique), which transformed the approach of the clinical microbiologists in viewing and using nucleic acid techniques in clinical settings.

Nucleic Acid Isolation & Purification Market Trends

The Equipment Segment is Expected to Hold a Major Market Share in the Nucleic Acid Isolation and Purification Market

  • The equipment segment of the market studied is growing at a good pace. There are significant advancements found in the field of molecular diagnostics that have facilitated rapid and continued advancements in nucleic acid isolation and purification technologies, driven by the new knowledge provided by the mapping of genetic risk factors behind many diseases, where lifestyle has an important role to play.
  • According to the World Health Organization (WHO) 2020, the alpha and beta thalassaemias are the most common inherited single-gene disorders in the world. The burden of thalassaemias in many regions of the world represents a major public health concern. For example in Iran, it was estimated that each year about 8,000 pregnancies are at risk of this disorder. Moreover, In addition, it was estimated that the incidence of genetic disorder Down syndrome was between 1 in 1,000 to 1 in 1,100 live births worldwide.
  • Thus, the high incidence of genetic disorders along with growth in laboratory automation and decreasing changeability may lead to the growth of the equipment segment of the market studied.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

  • North America is expected to hold a major market share in the nucleic acid isolation and purification market due to the very high use of downstream processes in the country. The growth of the market is also attributed due to the rapid technological advances, wide-range applications of nucleic acid testing in diagnostics boosting the market, rise in the R&D funding in biotechnology and healthcare.
  • According to the Centers for Disease Control and Prevention (CDC), in the United States Hemophilia A affects 1 in 5,000 male births. Each year approximately 400 babies are born with haemophilia A.
  • Furthermore, the presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.

Nucleic Acid Isolation & Purification Market Competitor Analysis

The Nucleic Acid Isolation and Purification Market is fragmented competitive and consists of several major players. Some of the recent market trends in the global nucleic acid isolation and purification market are new product development, mergers and acquisition, and partnerships. Agilent Technologies, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, GE Healthcare, Promega Corporation, Qiagen NV, and Thermo Fisher Scientific Inc. are some of the major players in the nucleic acid isolation and purification market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rapid Technological Advancements Boosting the Market Growth
    • 4.2.2 Wide-range Applications of Nucleic Acid Testing in Diagnostics Boosting the Market
    • 4.2.3 Rise in the R&D Funding in Biotechnology and Healthcare
  • 4.3 Market Restraints
    • 4.3.1 Low Penetration in the Emerging Markets
    • 4.3.2 Increasing Cost of Automated Instruments
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Technology
    • 5.1.1 Column-based Purification
    • 5.1.2 Magnetic Bead-based Purification
    • 5.1.3 Reagent-based Purification
  • 5.2 By Product
    • 5.2.1 Kits and Reagents
    • 5.2.2 Equipment
    • 5.2.3 Other Products
  • 5.3 By Application
    • 5.3.1 Total RNA Isolation and Purification
    • 5.3.2 mRNA Isolation and Purification
    • 5.3.3 microRNA Isolation and Purification
    • 5.3.4 Plasmid DNA Isolation and Purification
    • 5.3.5 Genomic DNA Isolation and Purification
    • 5.3.6 Blood DNA Isolation and Purification
    • 5.3.7 PCR Clean-up
    • 5.3.8 Other Nucleic Acid Isolation and Purification Applications
  • 5.4 By End User
    • 5.4.1 Hospitals
    • 5.4.2 Academic and Research Institutes
    • 5.4.3 Pharmaceutical/Biotechnology Industry
    • 5.4.4 Other End Users
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle-East & Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle-East & Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agilent Technologies
    • 6.1.2 Bio-Rad Laboratories Inc.
    • 6.1.3 Thermo Fisher Scientific
    • 6.1.4 BioVision Inc.
    • 6.1.5 Danaher Corporation
    • 6.1.6 F. Hoffmann-La Roche Ltd
    • 6.1.7 GE Healthcare
    • 6.1.8 Merck KGaA (Sigma-Aldrich Corporation)
    • 6.1.9 Promega Corporation
    • 6.1.10 Qiagen NV

7 MARKET OPPORTUNITIES AND FUTURE TRENDS